3828 Results

People

  1. Motzer
    Motzer
  2. Saltz
    Saltz
  3. Kris
    Kris
  4. Hudis
    Hudis
  5. Norton
    Norton
  6. Scher
    Scher
  7. Kelsen
    Kelsen
  8. Seidman
    Seidman
  9. Minsky
    Minsky
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (1879)
  2. Solid Tumor Oncology Division (1337)
  3. Surgery (732)
  4. Survivorship Research (538)
  5. Hematologic Malignancies, Division of (488)
  6. Center for Hematologic Malignancies (436)
  7. GSK Faculty (429)
  8. Epidemiology and Biostatistics (402)
  9. Sloan Kettering Institute Faculty (379)
  10. Population Sciences Research Program (343)
  1. "clinical trial"
Formats
  1. Journal Article (3682)
  2. Conference Paper (68)
  3. Meeting Abstract (25)
  4. Review (25)
  5. Research Letter (11)
  6. Editorial (8)
  7. Book Section (5)
  8. Correspondence (2)
  9. Guidelines (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (1879)
  2. Solid Tumor Oncology Division (1337)
  3. Surgery (732)
  4. Survivorship Research (538)
  5. Hematologic Malignancies, Division of (488)
  6. Center for Hematologic Malignancies (436)

More Groups

People
  1. Robert Motzer (117)
  2. Leonard Saltz (114)
  3. Mark Kris (107)
  4. Clifford Hudis (103)
  5. Larry Norton (90)
  6. Howard Scher (88)

More People

Years
  1. 2024 (49)
  2. 2023 (183)
  3. 2022 (142)
  4. 2021 (41)
  5. 2020 (36)
  6. 2019 (26)

More Years

Publications
  1. Journal of Clinical Oncology (338)
  2. Clinical Cancer Research (155)
  3. Cancer (138)
  4. New England Journal of Medicine (87)
  5. Seminars in Oncology (87)
  6. Journal of the National Comprehensive Cancer Network (72)

More Publications

Publishers
  1. Elsevier Inc. (637)
  2. American Society of Clinical Oncology (343)
  3. Springer (319)
  4. Elsevier Science, Inc. (219)
  5. Wiley Blackwell (218)
  6. Lippincott Williams & Wilkins (217)

More Publishers

Results (3828)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world clinical outcomes of patients with metastatic renal cell carcinoma receiving pembrolizumab + axitinib vs. ipilimumab + nivolumab
    Journal Article

    Shah, N. J.; Sura, S. D.; Shinde, R.; Shi, J.; Singhal, P.; Perini, R. F.; Motzer, R. J.
    Urologic Oncology: Seminars and Original Investigations (2023)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab in advanced salivary gland cancer: A phase 2 trial
    Journal Article

    Vos, J. L.; Burman, B.; Jain, S.; Fitzgerald, C. W. R.; Sherman, E. J.; Dunn, L. A.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Ng, K. K.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma
    Journal Article

    Fried, S.; Shkury, E.; Itzhaki, O.; Sdayoor, I.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Shouval, R.; Kedmi, M.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B
    Journal Article

    Le, X.; Paz-Ares, L. G.; Van Meerbeeck, J.; Viteri, S.; Galvez, C. C.; Smit, E. F.; Garassino, M.; Veillon, R.; Baz, D. V.; Pradera, J. F.; more...
    Cell Reports Medicine (2023)

    Fulltext@MSK | Save
  • Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial
    Journal Article

    Kubicki, T.; Dytfeld, D.; Wróbel, T.; Jamroziak, K.; Robak, P.; Czyż, J.; Tyczyńska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Szczepaniak, T.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Propensity-score matched and coarsened-exact matched analysis comparing robotic and laparoscopic major hepatectomies: An international multicenter study of 4822 cases
    Journal Article

    Liu, Q.; Zhang, W.; Zhao, J. J.; Syn, N. L.; Cipriani, F.; Alzoubi, M.; Aghayan, D. L.; Siow, T. F.; Lim, C.; Scatton, O.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
    Journal Article

    Rosenberg, J. E.; Powles, T.; Sonpavde, G. P.; Loriot, Y.; Duran, I.; Lee, J. L.; Matsubara, N.; Vulsteke, C.; Castellano, D.; Mamtani, R.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • Phase Ib/II study of the efficacy and safety of binimetinib (MEK162) plus panitumumab for mutant or wild-type RAS metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Yaeger, R.; Delord, J. P.; Tabernero, J.; Siu, L. L.; Ducreux, M.; Siena, S.; Elez, E.; Kasper, S.; Zander, T.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save